Chairman & Chief Executive Officer
Andrew Tussing is Chairman and Chief Executive Officer of Vaccinogen, Inc. He is a co-founder of the company and Chairman of the Board of Directors.
Mr. Tussing has a track record of building companies and co-founded Vaccinogen along with Dr. Hanna in 2007. Since then he has served as Vaccinogen’s President, Chief Operating Officer and acting Chief Financial Officer. In these roles, he oversaw the financial and operational management of the company and led several initiatives; including establishing and maintaining the Dutch manufacturing facility that will make patient-specific doses of OncoVAX® necessary to support the company’s phase IIIb study. Mr. Tussing was also responsible for all the capital raises and drove the process to take the company public.
Previously, Mr. Tussing was active in investment banking at 1st BridgeHouse Securities, a co-founder of Milestone International Asset Management and served in senior roles at Pershing, a division of the Bank of New York, Deutsche Bank Alex. Brown as Director of Strategic Development, Marketing & Sales for its Correspondent Services business and founded both Tussing Associates and TM Resources. Mr. Tussing has a BS in Business Administration from the University of Baltimore.